Background Background Acute tryptophan
Acute tryptophan depletion transiently induces symptoms in depletion transiently induces symptoms in those with remitted depression.The those with remitted depression.The behavioural specificity is uncertain, behavioural specificity is uncertain, however.Recently, symptom provocation however.Recently, symptom provocation studies have become controversial, studies have become controversial, particularly in the USA. particularly in the USA.
Aims Aims To assess the specificity of acute
To assess the specificity of acute tryptophan depletion.To investigate tryptophan depletion.To investigate systematically the subjective experiences systematically the subjective experiences ofthose taking part in a symptom of those taking part in a symptom provocation study. provocation study.
Method Method Twenty individuals with
Twenty individuals with remitted depression underwent acute remitted depression underwent acute tryptophan depletion in a double-blind, tryptophan depletion in a double-blind, crossover trial.Psychiatric symptoms and crossover trial.Psychiatric symptoms and self-schemata relevantto depression were self-schemata relevantto depression were assessed.The quality of the informed assessed.The quality of the informed consent procedure and subjective consent procedure and subjective experiences were also evaluated. experiences were also evaluated.
Results

Results Acute tryptophan depletion
Acute tryptophan depletion induced a specific depressive response. induced a specific depressive response. The effects were more pronounced in The effects were more pronounced in females than in males.Participants were females than in males.Participants were quite satisfied with the informed consent quite satisfied with the informed consent procedure.They had understood thatthis procedure.They had understood thatthis was a fundamental research project and was a fundamental research project and personal benefits were not expected. personal benefits were not expected. However, some participants still found it a However, some participants still found it a positive experience. positive experience.
Conclusions Conclusions Acute tryptophan
Acute tryptophan depletion is a suitable model of depletion is a suitable model of vulnerability to depression, from both a vulnerability to depression, from both a scientific and an ethical perspective. scientific and an ethical perspective.
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Acute tryptophan depletion induces Acute tryptophan depletion induces transient symptoms in 50-60% of those transient symptoms in 50-60% of those with remitted depression treated with a with remitted depression treated with a serotonergic antidepressant (Booij serotonergic antidepressant (Booij et al et al, , 2003) . Evidence suggests that it causes a 2003). Evidence suggests that it causes a return of symptoms that were present bereturn of symptoms that were present before treatment (Delgado fore treatment (Delgado et al et al, 1990 (Delgado et al et al, ), but , 1990 ), but others argue that it mainly induces physical others argue that it mainly induces physical symptoms (Lam & Yatham symptoms (Lam & Yatham, 2003) . Studies , 2003) . Studies have almost exclusively relied on the have almost exclusively relied on the Hamilton Rating Scale for Depression Hamilton Rating Scale for Depression (HRSD), which includes many somatic (HRSD), which includes many somatic items (Hamilton, 1960) . Hence, the behavitems (Hamilton, 1960) . Hence, the behavioural specificity of acute tryptophan depleioural specificity of acute tryptophan depletion is still uncertain. Furthermore, tion is still uncertain. Furthermore, symptom provocation studies are now consymptom provocation studies are now controversial. For instance, front-page articles troversial. For instance, front-page articles in in The Boston Globe
The Boston Globe (Whitaker & Kong, (Whitaker & Kong, 1998) accused researchers of abusing pa-1998) accused researchers of abusing patients for financial profit or professional tients for financial profit or professional advancement. No lasting or serious sideadvancement. No lasting or serious sideeffects have been reported for acute tryptoeffects have been reported for acute tryptophan depletion, suggesting that the phan depletion, suggesting that the procedure is safe. However, the views of procedure is safe. However, the views of participants have not been investigated. participants have not been investigated. The aims of the present study were to The aims of the present study were to investigate the behavioural specificity of investigate the behavioural specificity of acute tryptophan depletion and to collect acute tryptophan depletion and to collect data on participants' opinions on a depledata on participants' opinions on a depletion study. tion study.
METHOD METHOD Participants Participants
Eligible participants for the acute tryptoEligible participants for the acute tryptophan depletion trial were out-patients of a phan depletion trial were out-patients of a mood disorders clinic. Inclusion criteria mood disorders clinic. Inclusion criteria were: age between 18 and 65 years; onwere: age between 18 and 65 years; ongoing treatment with a selective serotonin going treatment with a selective serotonin reuptake inhibitor (SSRI) or serotoninreuptake inhibitor (SSRI) or serotoninnoradrenaline reuptake inhibitor (SNRI) noradrenaline reuptake inhibitor (SNRI) for at least 4 weeks; meeting DSM-IV for at least 4 weeks; meeting DSM-IV criteria for depression in remission criteria for depression in remission (American Psychiatric Association, 1994) ; (American Psychiatric Association, 1994) ; and an HRSD (17-item version) score lower and an HRSD (17-item version) score lower than 15. Exclusion criteria were: major than 15. Exclusion criteria were: major physical illness; substance misuse within physical illness; substance misuse within the past 3 months; psychosis (lifetime); the past 3 months; psychosis (lifetime); lactation; and pregnancy. Diagnoses were lactation; and pregnancy. Diagnoses were clarified with the Structured Clinical Interclarified with the Structured Clinical Interview for DSM-IV (SCID; First view for DSM-IV (SCID; First et al et al, , 1995) . After a complete oral and written 1995). After a complete oral and written description of the study, written informed description of the study, written informed consent was obtained. Twenty-three parconsent was obtained. Twenty-three participants were enrolled in the trial, two of ticipants were enrolled in the trial, two of whom subsequently withdrew. whom subsequently withdrew.
After the tryptophan challenge, all 23 After the tryptophan challenge, all 23 participants, together with a further 18 participants, together with a further 18 (10 females) who had participated in (10 females) who had participated in another acute tryptophan depletion project, another acute tryptophan depletion project, were asked to complete a questionnaire were asked to complete a questionnaire about their experiences during the study. about their experiences during the study. Participants in the other project also had Participants in the other project also had remitted depression and the design, proremitted depression and the design, procedure and inclusion criteria of that project cedure and inclusion criteria of that project were identical to the present study. were identical to the present study.
Design Design
The study had a randomised double-blind The study had a randomised double-blind crossover design with two depletion crossover design with two depletion sessions, separated by at least 4 days. The sessions, separated by at least 4 days. The hospital pharmacist was responsible for hospital pharmacist was responsible for the randomisation. the randomisation.
Amino acid mixtures Amino acid mixtures
At each depletion session, patients received At each depletion session, patients received in randomised order either a 100 g or a 25 g in randomised order either a 100 g or a 25 g amino acid mixture. The composition of amino acid mixture. The composition of the 100 g mixture (aimed at reducing trypthe 100 g mixture (aimed at reducing tryptophan levels by 90%) was as follows: tophan levels by 90%) was as follows:
.0 g L L-lysine HCL -lysine HCL and 3.2 g glycine. The 25 g mixture (aimed and 3.2 g glycine. The 25 g mixture (aimed at 50% reduction) consisted of the same at 50% reduction) consisted of the same amino acids but in one-quarter the amount amino acids but in one-quarter the amount (Krahn (Krahn et al et al, 1996) . Amino acids were , 1996). Amino acids were mixed with cold water to a final volume mixed with cold water to a final volume of 300 ml. Liquid chocolate syrup was of 300 ml. Liquid chocolate syrup was added, and the mixture was served chilled added, and the mixture was served chilled to limit the unpleasant taste of some of to limit the unpleasant taste of some of the amino acids. Participants were kept on the amino acids. Participants were kept on a 24-h low-tryptophan diet (160 mg/day) a 24-h low-tryptophan diet (160 mg/day) prior to both sessions. During the depletion prior to both sessions. During the depletion sessions, water, (de)caffeinated coffee, (herb) sessions, water, (de)caffeinated coffee, (herb) tea, orange juice and protein-poor ( tea, orange juice and protein-poor (5 50.05 g) 0.05 g) biscuits were allowed in standard amounts. biscuits were allowed in standard amounts. Patients had a low-tryptophan lunch 3 h Patients had a low-tryptophan lunch 3 h after drinking the mixture. after drinking the mixture.
Assessments Assessments
We used the Comprehensive PsychopathoWe used the Comprehensive Psychopathological Rating Scale (CPRS) to assess symplogical Rating Scale (CPRS) to assess symptoms (Goekoop toms (Goekoop et al et al, 1992 et al, 1984) . Fac-, 1984) . Factor analytic research has revealed that the tor analytic research has revealed that the CPRS consists of six factors (Goekoop CPRS consists of six factors (Goekoop et et al al, 1992) . Emotional dysregulation refers , 1992). Emotional dysregulation refers to a number of symptoms common to both to a number of symptoms common to both anxiety and depression. Motivational inhianxiety and depression. Motivational inhibition refers to dysregulation of appetite, bition refers to dysregulation of appetite, interest and motor inhibition, whereas interest and motor inhibition, whereas motor disinhibition refers to 'manic-like' motor disinhibition refers to 'manic-like' symptoms. The subscale behavioural disinsymptoms. The subscale behavioural disintegration refers to items such as agitation, tegration refers to items such as agitation, slowness of movement and emotional indifslowness of movement and emotional indifference. Perceptual disintegration refers to ference. Perceptual disintegration refers to psychotic symptoms. Autonomic dysregulapsychotic symptoms. Autonomic dysregulation measures autonomic arousal/anxiety. tion measures autonomic arousal/anxiety. For the present study, a number of quesFor the present study, a number of questions were added to the CPRS interview, tions were added to the CPRS interview, to allow scoring of the 17-item HRSD. to allow scoring of the 17-item HRSD. Ratings were performed by a trained interRatings were performed by a trained interviewer who was masked to the sequence of viewer who was masked to the sequence of the mixtures and to the research question the mixtures and to the research question (i.e. the specificity question). (i.e. the specificity question).
Self-report measures included the Beck Self-report measures included the Beck Depression Inventory II (BDI-II; Beck Depression Inventory II (BDI-II; Beck et et al al, 1996) and the Positive and Negative , 1996) and the Positive and Negative Affect Schedule (PANAS; Watson Affect Schedule (PANAS; Watson et al et al, , 1988) . The BDI-II is more focused on cog-1988). The BDI-II is more focused on cognitions than other depression scales, and nitions than other depression scales, and has three subscales: affective, somatic, coghas three subscales: affective, somatic, cognitive (Van der Does, 2002) . The PANAS is nitive (Van der Does, 2002) . The PANAS is based on the tripartite model of anxiety and based on the tripartite model of anxiety and depression (Watson depression (Watson et al et al, 1988) . It mea-, 1988) . It measures negative affect (common to anxiety/ sures negative affect (common to anxiety/ distress and depression) and positive affect distress and depression) and positive affect (low scores specific for depression). Partici-(low scores specific for depression). Participants also rated a list of 48 physical symppants also rated a list of 48 physical symptoms on a five-point scale. toms on a five-point scale.
The Self-referent Adjectives Encoding The Self-referent Adjectives Encoding and Recall Task (SAERT; Dobson & Shaw, and Recall Task (SAERT; Dobson & Shaw, 1987) was used to assess self-schemata rele-1987) was used to assess self-schemata relevant to depression. The task consists of a vant to depression. The task consists of a random presentation of ten positive and random presentation of ten positive and ten negative adjectives and six neutral ten negative adjectives and six neutral words, preceded by three neutral practice words, preceded by three neutral practice trials. Words were selected from a validated trials. Words were selected from a validated list of personality trait words (Anderson, list of personality trait words and matched on word frequency, 1968) and matched on word frequency, word length and number of syllables. Each word length and number of syllables. Each word was presented twice. At the first preword was presented twice. At the first presentation, participants had to decide as sentation, participants had to decide as quickly as possible whether or not the word quickly as possible whether or not the word was self-descriptive. Immediately therewas self-descriptive. Immediately thereafter, the same word was presented again, after, the same word was presented again, accompanied by a six-point scale ranging accompanied by a six-point scale ranging from from 7
73 (not at all applicable) to +3 3 (not at all applicable) to +3
(very applicable). Response speed was (very applicable). Response speed was emphasised for the initial (yes/no) ratings, emphasised for the initial (yes/no) ratings, not for the second presentation. Immedinot for the second presentation. Immediately after the second presentation, particiately after the second presentation, participants were asked to recall the adjectives pants were asked to recall the adjectives presented. presented.
Ethics questionnaire Ethics questionnaire
The questionnaire contained 28 items conThe questionnaire contained 28 items concerning the quality of the informed consent cerning the quality of the informed consent procedure and participants' experiences procedure and participants' experiences during the study. Reasons for participation during the study. Reasons for participation were also collected. The questionnaire was were also collected. The questionnaire was completed anonymously; a code could link completed anonymously; a code could link the questionnaire data to the project in the questionnaire data to the project in which the individual had participated. which the individual had participated. The psychometric properties of the The psychometric properties of the questionnaire are unknown. questionnaire are unknown.
Blood plasma Blood plasma
We collected venous blood (10 ml) into We collected venous blood (10 ml) into tubes containing ethylenediamine tetratubes containing ethylenediamine tetraacetic acid (EDTA) to determine the total acetic acid (EDTA) to determine the total plasma tryptophan concentration and the plasma tryptophan concentration and the ratio of total tryptophan to large neutral ratio of total tryptophan to large neutral amino acids. Immediately after sampling, amino acids. Immediately after sampling, plasma was centrifuged for 20 min at plasma was centrifuged for 20 min at 2650 2650 g g and frozen at and frozen at 7 765 65 8 8C prior to C prior to quantitative amino acid analysis by highquantitative amino acid analysis by highperformance liquid chromatography performance liquid chromatography (Fekkes (Fekkes et al et al, 1995) . , 1995).
Procedure Procedure
After receiving oral and written inforAfter receiving oral and written information about the study, eligible particimation about the study, eligible participants were invited to a screening pants were invited to a screening interview that included the SCID-IV, the interview that included the SCID-IV, the HRSD and MADRS questionnaires and an HRSD and MADRS questionnaires and an interview with a dietician. During day 1 interview with a dietician. During day 1 of each session, participants consumed the of each session, participants consumed the prepacked low-tryptophan meals. Participrepacked low-tryptophan meals. Participants arrived at the laboratory the next pants arrived at the laboratory the next morning (8 or 9 a.m.) after an overnight morning (8 or 9 a.m.) after an overnight fast. Symptoms and side-effects were fast. Symptoms and side-effects were assessed at baseline (arrival at the laboraassessed at baseline (arrival at the laboratory) ( tory) (7 71 h), +6.5 h and the next morning 1 h), +6.5 h and the next morning (+24 h). The SAERT was conducted at both (+24 h). The SAERT was conducted at both sessions at +4.5 h. Blood samples were sessions at +4.5 h. Blood samples were taken at taken at 7 71 h, at +6 h and at +24 h. All 1 h, at +6 h and at +24 h. All participants were tested individually and participants were tested individually and were paid were paid e e115 for participation. 115 for participation. At the end of their participation, indiAt the end of their participation, individuals were asked to complete the ethics viduals were asked to complete the ethics questionnaire and to mail it in a prepaid questionnaire and to mail it in a prepaid envelope to an independent investigator. envelope to an independent investigator. The address was a university in a different The address was a university in a different city, and it was emphasised that the data city, and it was emphasised that the data would remain confidential. To test whether would remain confidential. To test whether the questions were well understood, we the questions were well understood, we administered the questionnaire in a semiadministered the questionnaire in a semistructured interview format to the first four structured interview format to the first four participants. The results did not differ from participants. The results did not differ from the other completed questionnaires. The the other completed questionnaires. The study was approved by an independent study was approved by an independent medical ethics committee. medical ethics committee.
Statistical analysis Statistical analysis
All variables were examined for accuracy of All variables were examined for accuracy of data entry, missing values and fit between data entry, missing values and fit between their distributions and the assumptions of their distributions and the assumptions of data analysis. To analyse the mood ratings, data analysis. To analyse the mood ratings, we used general linear models (GLM) for we used general linear models (GLM) for repeated measures with intervention repeated measures with intervention (100 g amino acids (100 g amino acids v.
v. 25 g amino acids) 25 g amino acids) and time of assessment (preand time of assessment (pre-v.
v. postpostdepletion depletion v v. the next day) as within-subject . the next day) as within-subject factors and gender as a between-subject factors and gender as a between-subject factor. Contrasts tested for differences factor. Contrasts tested for differences between specific time points. between specific time points.
Although the choice of the scales was Although the choice of the scales was based on prior research and theoretical conbased on prior research and theoretical considerations, a more stringent level of siderations, a more stringent level of a a may may be needed to keep overall be needed to keep overall a a under control. under control. This could cause a power problem, This could cause a power problem, although the sample size of our study is although the sample size of our study is comparable with those of other acute comparable with those of other acute tryptophan depletion studies. To correct tryptophan depletion studies. To correct for multiple comparisons and to retain for multiple comparisons and to retain reasonable power, we set reasonable power, we set a a at 0.15 at 0.15 (Stevens, 1996) . Because there were 14 (Stevens, 1996) . Because there were 14 sub-scales, each variable was tested at sub-scales, each variable was tested at the 0.15/14 the 0.15/14¼0.01 level of significance.
0.01 level of significance. Contrast tests were not corrected because Contrast tests were not corrected because they were planned. they were planned.
For each significant scale, effect size For each significant scale, effect size (Cohen's (Cohen's d d) was calculated as follows ) was calculated as follows (Cortina & Nouri, 2000; Rosnow & (Cortina & Nouri, 2000; Rosnow & Rosenthal, 2003) : Rosenthal, 2003): For the SAERT, intervention was the For the SAERT, intervention was the only within-subject factor. Clinical and only within-subject factor. Clinical and demographic variables were analysed by demographic variables were analysed by univariate GLM and univariate GLM and w w 2 2 -tests.
-tests.
RESULTS RESULTS
Demographic data Demographic data
Of 23 individuals who satisfied the incluOf 23 individuals who satisfied the inclusion criteria, 21 completed the study. Two sion criteria, 21 completed the study. Two (both male) withdrew after the first session; (both male) withdrew after the first session; the first owing to a severe headache on the the first owing to a severe headache on the depletion day (after 25 g amino acids), the depletion day (after 25 g amino acids), the second because of health problems after the second because of health problems after the first session (100 g amino acids) unlikely to first session (100 g amino acids) unlikely to be caused by acute tryptophan depletion. be caused by acute tryptophan depletion. These two are not included in the analyses. These two are not included in the analyses. One female participant vomited about One female participant vomited about 10 min after ingestion of the 100 g mixture, 10 min after ingestion of the 100 g mixture, but she was able to complete both sessions. but she was able to complete both sessions. Because the reduction of plasma tryptoBecause the reduction of plasma tryptophan levels with the 100 g mixture in this phan levels with the 100 g mixture in this participant was only marginally higher than participant was only marginally higher than with the 25 g mixture (64% with the 25 g mixture (64% v. v. 55%), and 55%), and much lower than the average reduction much lower than the average reduction with the 100 g mixture (see below), this with the 100 g mixture (see below), this individual was also excluded. individual was also excluded.
Data screening Data screening
One participant missed one item on the One participant missed one item on the PANAS positive scale; this item score was PANAS positive scale; this item score was replaced by the mean of the remaining replaced by the mean of the remaining items for that individual on that scale. items for that individual on that scale. Using Mahalonobis distances and the Using Mahalonobis distances and the standardised residuals criterion, we destandardised residuals criterion, we detected an outlier on the MADRS and CPRS tected an outlier on the MADRS and CPRS sub-scales of emotional dysregulation sub-scales of emotional dysregulation and motivational inhibition ( and motivational inhibition (d d Table 1 . are presented in Table 1 .
Biochemical effects Biochemical effects
Full depletion significantly reduced total Full depletion significantly reduced total tryptophan and the tryptophan/large tryptophan and the tryptophan/large neutral amino acids ratio at +6 h by 86% neutral amino acids ratio at +6 h by 86% (s. 
Symptoms Symptoms
The behavioural effects of both the 25 g and The behavioural effects of both the 25 g and 100 g mixtures are presented in Table 2 . 100 g mixtures are presented in P¼0.009). The MADRS change 0.009). The MADRS change score data revealed two clearly separable score data revealed two clearly separable groups 7 participants had a mood change groups 7 participants had a mood change of at least six points (range 6-12) and the of at least six points (range 6-12) and the remaining 13 participants had no mood remaining 13 participants had no mood change (range change (range 7 71 to +2). The HRSD gave 1 to +2). The HRSD gave a comparable division, but less clearly sea comparable division, but less clearly separable groups: 7 participants had a change parable groups: 7 participants had a change of at least three points (range 3-6), the of at least three points (range 3-6), the remaining participants had smaller or no remaining participants had smaller or no changes (range changes (range 7 72 to +2). The agreement 2 to +2). The agreement between the two scales was 90% (kappa between the two scales was 90% (kappa 0.56, 0.56, P P¼0.01). The interaction for the 0.01). The interaction for the BDI-cognitive sub-scale approached sig-BDI-cognitive sub-scale approached significance ( nificance (F F¼3.3, d.f. 3.3, d .f.¼2,36, 2,36, P P¼0.05) and 0.05) and the BDI-total was significant ( the BDI-total was significant (F F¼3.9, 3.9, d.f. d.f.¼2,36, 2,36, P P¼0.03). 0.03).
The total number of side-effects The total number of side-effects decreased in both sessions. Scores that were decreased in both sessions. Scores that were notably lower at notably lower at t t¼+6.5 h compared with +6.5 h compared with t t¼7 71 h were 'angry/irritable', 'sweating' 1 h were 'angry/irritable', 'sweating' and 'tension'. Scores on the items 'nausea' and 'tension'. Scores on the items 'nausea' and 'feel sick' increased, with no differences and 'feel sick' increased, with no differences between conditions. between conditions.
Self-referent Adjectives Encoding Self-referent Adjectives Encoding and Recall Task (SAERT) and Recall Task (SAERT)
Prior to analysis, consistency of the answers Prior to analysis, consistency of the answers across presentations was checked. Inconsisacross presentations was checked. Inconsistent answers (e.g. if a participant pressed tent answers (e.g. if a participant pressed the 'yes' button for the word 'lazy' and then the 'yes' button for the word 'lazy' and then rated it as 'not applicable' on second rating) rated it as 'not applicable' on second rating) were analysed separately. Outcome meawere analysed separately. Outcome measures were highly skewed, except for persures were highly skewed, except for percentage of words recalled. Reaction times centage of words recalled. Reaction times were log10 transformed. Non-parametric were log10 transformed. Non-parametric tests were used for the other skewed varitests were used for the other skewed variables of the SAERT because transformaables of the SAERT because transformations were unsuccessful. tions were unsuccessful.
Participants were more likely to rate Participants were more likely to rate positive than negative traits as selfpositive than negative traits as selfdescriptive, and they needed less time for descriptive, and they needed less time for positive than for negative traits to decide positive than for negative traits to decide whether they were self-descriptive. There whether they were self-descriptive. There was no main effect of acute tryptophan was no main effect of acute tryptophan depletion. 1.0)). Participants who were inconsistent usually first pressed the 'yes' inconsistent usually first pressed the 'yes' button (under time pressure) and then button (under time pressure) and then rated it as 'not applicable' (full deplerated it as 'not applicable' (full depletion: 17 times; partial depletion: 18 times); tion: 17 times; partial depletion: 18 times); the reverse happened only once under both the reverse happened only once under both conditions. conditions.
There were significant effects of inThere were significant effects of intervention ( tervention (F F¼4.7 v. 2% relative 2% relative to partial depletion). There were no other to partial depletion). There were no other differences between responders and nondifferences between responders and nonresponders. responders.
Computation of effect sizes Computation of effect sizes
Cohen's Cohen's d d for the significant symptom for the significant symptom scales are displayed in Table 3 . scales are displayed in Table 3 . ( 5); fluoxetine (n n¼2); citalopram 2); citalopram ( (n n¼2); fluvoxamine ( 2); fluvoxamine (n n¼2); sertraline ( 2); sertraline (n n¼2). 2). 5. Venlafaxine (75^225 mg) ( 5. Venlafaxine (75^225 mg) (n n¼5); nefazodone 5); nefazodone hydrochloride (150 mg) ( hydrochloride (150 mg) (n n¼2). 2).
Gender effects Gender effects
At baseline, there were no significant demoAt baseline, there were no significant demographic or clinical differences between graphic or clinical differences between males and females (Fig. 1) . Morning males and females (Fig. 1) The increase of MADRS scores between The increase of MADRS scores between t t¼7 71 h and 1 h and t t¼+6.5 h after full depletion +6.5 h after full depletion was larger in females (Fig. 1) . All was larger in females (Fig. 1) . All responders were women. Females also responders were women. Females also tended to have a larger increase of BDItended to have a larger increase of BDIsomatic scores than males in the full somatic scores than males in the full depletion condition at depletion condition at t t¼+6.5 h ( +6.5 h (P P¼0.07). 0.07). Table 4 . All participants were quite satisfied with the informed consent prosatisfied with the informed consent procedure and reported that they had felt concedure and reported that they had felt confident to decide whether to participate. fident to decide whether to participate. More than half reported that participation More than half reported that participation in the study had changed their perception in the study had changed their perception of their illness. Changes that were menof their illness. Changes that were mentioned included that the study had helped tioned included that the study had helped them to gain more insight and facilitated them to gain more insight and facilitated acceptance of being vulnerable. Some acceptance of being vulnerable. Some participants mentioned that the transient participants mentioned that the transient return of symptoms had made them realise return of symptoms had made them realise how much they had improved during treathow much they had improved during treatment. Two participants interpreted their ment. Two participants interpreted their experiences as evidence for a biological experiences as evidence for a biological cause of their depression, and felt less cause of their depression, and felt less responsible. All changes were perceived as responsible. All changes were perceived as positive. positive.
Order of administration Order of administration
The informed consent procedure had The informed consent procedure had been very well understood. In response to been very well understood. In response to a question about whether the participant a question about whether the participant expected to get better treatment after partiexpected to get better treatment after participation, 90% ( cipation, 90% (n n¼32) answered 'not at all' 32) answered 'not at all' and 11% ( and 11% (n n¼4) 'slightly'. Regarding moti-4) 'slightly'. Regarding motivation to participate (open-ended quesvation to participate (open-ended question), 58% ( tion), 58% (n n¼21) wanted to contribute 21) wanted to contribute to the development of better treatments in to the development of better treatments in the future. Others participated because of the future. Others participated because of gratefulness towards the hospital or general gratefulness towards the hospital or general interest in science. Two participants also interest in science. Two participants also mentioned financial reasons. mentioned financial reasons.
There were no significant differences There were no significant differences between the two projects on any of the between the two projects on any of the items investigated. The evaluation of the items investigated. The evaluation of the identified withdrawals was not different identified withdrawals was not different from the other participants. One who withfrom the other participants. One who withdrew (a female mood responder) had felt drew (a female mood responder) had felt unprepared for how big the effect would unprepared for how big the effect would be, but she still reported that the study be, but she still reported that the study had been helpful, in the sense that it had had been helpful, in the sense that it had convinced her that she is less responsible convinced her that she is less responsible for her depression than she had thought. for her depression than she had thought.
DISCUSSION DISCUSSION
Could the depletion procedure Could the depletion procedure be explained well to participants? be explained well to participants?
Symptom provocation studies have become Symptom provocation studies have become controversial, particularly in the USA. controversial, particularly in the USA. Questions have been raised concerning the Questions have been raised concerning the risk/benefit ratio for participants, their risk/benefit ratio for participants, their capacity to decide whether to participate capacity to decide whether to participate and the provision of adequate informed and the provision of adequate informed consent (Miller & Rosenstein, 1997; consent (Miller & Rosenstein, 1997; Michels, 1999) . This is the first acute trypMichels, 1999) . This is the first acute tryptophan depletion study to systematically tophan depletion study to systematically collect the views of participants. Individcollect the views of participants. Individuals did not regret participating, and they uals did not regret participating, and they had understood the informed consent prohad understood the informed consent procedure. Despite the provocation of sympcedure. Despite the provocation of symptoms and the fact that there was no direct toms and the fact that there was no direct benefit, some participants still experienced benefit, some participants still experienced personal advantages. Two interpreted their personal advantages. Two interpreted their experiences as evidence of a biological basis experiences as evidence of a biological basis for their depression and felt less responsible for their depression and felt less responsible for their illness. The influence of this on the for their illness. The influence of this on the future course of illness should be further future course of illness should be further investigated, as well as the generalisability investigated, as well as the generalisability to other symptom provocation studies. To to other symptom provocation studies. To justify future challenge studies, it may be justify future challenge studies, it may be useful to routinely investigate participants' useful to routinely investigate participants' subjective experiences in this type of subjective experiences in this type of research. research.
Is the acute tryptophan depletion Is the acute tryptophan depletion response a specific model response a specific model of depressive relapse? of depressive relapse?
Full acute tryptophan depletion signifiFull acute tryptophan depletion significantly increased depressive symptoms as cantly increased depressive symptoms as measured by the MADRS and HRSD. The measured by the MADRS and HRSD. The MADRS increase was larger in females MADRS increase was larger in females than in males. The menstrual cycle was than in males. The menstrual cycle was not taken into account in the present study, not taken into account in the present study, but the finding is consistent with our but the finding is consistent with our pooled reanalysis of previous acute pooled reanalysis of previous acute tryptophan depletion studies (Booij tryptophan depletion studies (Booij et al et al, , 2002 (Booij et al et al, , ). 2002 .
Almost all acute tryptophan depletion Almost all acute tryptophan depletion studies in individuals with remitted depresstudies in individuals with remitted depression have relied exclusively on the HRSD, sion have relied exclusively on the HRSD, and no previous study has measured a and no previous study has measured a broad range of symptoms. However, some broad range of symptoms. However, some studies added self-report questionnaires studies added self-report questionnaires such as the Profile of Mood States, or prosuch as the Profile of Mood States, or provided qualitative descriptions of the 'revided qualitative descriptions of the 'relapse' (Smith lapse' (Smith et al et al, 1997; Lam & Yatham, , 1997; Lam & Yatham, 2003) . Full but not partial depletion 2003). Full but not partial depletion affected the CPRS sub-scales emotional affected the CPRS sub-scales emotional dysregulation, motivational inhibition and dysregulation, motivational inhibition and behavioural disintegration. No significant behavioural disintegration. No significant effects were found on the sub-scales motieffects were found on the sub-scales motivational disinhibition (elation, pressure of vational disinhibition (elation, pressure of speech, 'manic-like' symptoms), perceptual speech, 'manic-like' symptoms), perceptual disintegration (psychotic symptoms), autodisintegration (psychotic symptoms), autonomic dysregulation (autonomic arousal/ nomic dysregulation (autonomic arousal/ anxiety), or on the Brief Anxiety Scale. anxiety), or on the Brief Anxiety Scale. Similarly, depletion did not change PANAS Similarly, depletion did not change PANAS negative affect (common to anxiety and negative affect (common to anxiety and stress) but tended to decrease positive affect stress) but tended to decrease positive affect (indicative of depression). The lack of effect (indicative of depression). The lack of effect on anxiety is of interest, since different on anxiety is of interest, since different serotonergic projections and receptors serotonergic projections and receptors may mediate both depression and anxiety may mediate both depression and anxiety (Graeff (Graeff et al et al, 1996) . , 1996). It is noteworthy that the behavioural It is noteworthy that the behavioural changes following acute tryptophan changes following acute tryptophan 1 5 2 15 2 Did you expect to receive better treatment because you participated in this study? Did you expect to receive better treatment because you participated in this study?
(1 (1¼not at all, 4 not at all, 4¼very much) very much) 
